As a revolutionary treatment technology, ESWT affords the patient and the clinician a number of distinct benefits when using the Swiss DolorClast. These are:

For the patient:

  • No need for anaesthetic
  • Non-invasive procedure
  • No need for surgery or medication
  • Treatment sessions last for an average of only 15 minutes
  • No hospital admission
  • Transient analgesic effect after treatment
  • No lengthy rehabilitation, loss of mobility or time away from work
  • Fewer complications
  • Strong clinical results

For the clinician:

  • Lower time and financial cost
  • Broad range of applications
  • High patient acceptance
  • Simple procedure
  • Outstanding product reliability and quality
  • NICE guidance and FDA approved
  • European patent of ‘Dolorclast’
  • Low operating costs
  • Comprehensive product support
ESWT offers two main advantages over traditional surgical methods:
fewer potential complications and a faster return to normal activity.
FDA 2007